TNYA Tenaya Therapeutics, Inc.
Healthcare$0.78+1.23%ClosedMarket Cap: $130.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.11
P/S
572.01
EV/EBITDA
-0.75
DCF Value
$0.57
FCF Yield
-50.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
144.9%
Operating Margin
-38159.1%
Net Margin
-36891.1%
ROE
-80.6%
ROA
-61.5%
ROIC
-70.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $225.0K | -683.6% | $-20.1M | $-19.3M | $— | — |
| Q4 null | $0.00 | Infinity% | $-20.8M | $-20.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-93.3M | $-90.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-20.9M | $-20.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-24.1M | $-23.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-27.5M | $-26.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-24.7M | $-23.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-115.9M | $-111.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-26.7M | $-25.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-30.8M | $-29.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-33.8M | $-32.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-31.4M | $-29.9M | $-0.44 | — |